Atorvastatin as an immunomodulatory adjunct in ulcerative colitis, beyond lipid lowering to inflammation control: a randomized controlled pilot study.

Front Pharmacol · 2025 · PMC12605515 · PMID 41235106

Europe PMC DOI

hedged sentence

0.1150

closest p · 2.3× alpha

0.1150

boldest claim

The sentences

did not reach statistical significancep = 0.115not close (p > 0.1)

14.8%), though the difference did not reach statistical significance (p = 0.115) ( Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.